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Executive Summary 
Background 
This project was originated from the work of the Clinical Leadership Advisor / Controlled Drugs 
Accountable Officer at NHS England In July 2014. A business case was proposed to prove the concept 
that pharmacists in general practice could provide a range of services and relieve some of the 
pressures on primary medical services. (Travis, July 2014) The work reported in this chapter focuses on 
this early scoping and proof of concept work. 
This pilot is very timely. The primary care context has increasing demand (generated by a range of 
factors including political and austerity changes, an ageing population with increasing chronic illness 
and multimorbidity) and limited supply of general practice clinicians. The GP workforce 10 point plan 
(NHSE, 2015a) acknowledged that to address supply-demand imbalances GP practices would be 
encouraged to recruit pharmacists; the report laid out plans for a national pilot launching in 2015 with 
the first pharmacists working in General Practice on the pilot scheme by 2016 (NHSE, 2015b). 
The pilot scheme was a ‘proof of concept’ scheme seeking to evaluate and understand the proposition 
‘Community pharmacist independent prescribers (CPIPs) can play a positive role in general practice 
and have a positive impact at all levels - on patients, practices and the NHS’ 
A theory of change model was proposed to understand the implementation at multiple levels; the 
evaluation sought to understand the model on which the initiative was developed, the forms of 
evidence and experience which were influential and how a refined model of change can be used to 
inform future measurement and summative evaluation. The findings of the research are consolidated 
into the summary theory of change model presented at the end of this section. Take home messages 
are outlined. 
Methods 
The pilot scheme covered five CCGs in the East Midlands. Six general practices were recruited to the 
pilot scheme, matched to six pharmacists for a period of one year. Funding was provided to the 
employing community pharmacy as ‘buy out’ costs for the secondment. Pharmacists worked for a 
varying hours in each practice, between one and four days per week. Each site started at a differing 
point over 2015.  Routine service data collected by programme managers shows that CPIPs undertook 
over 13,000 consultations. The evaluation was commissioned to review the pilot scheme and evaluate 
the proof of concept across all sites. The qualitative ethnographic evaluation work commissioned to be 
undertaken by the University of Nottingham outlined a series of key questions relating to the 
operationalisation and outcomes of the pilot scheme. The total data set from the one year evaluation 
utilised 75 independent sources of data collected from over 96 direct participants. Observational data 
was collected on at least ten separate occasions, covering at least 45 patient consultations. Interviews 
were conducted with 18 primary care staff and 33 patients through 5 patient focus groups. Data was 
subject to interdisciplinary thematic analysis using emergent categories as well as the consolidated 
framework for implementation research. The findings inform the development of a change model 
from theory to practice.  
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Findings 
Implementation 
The management roles were vital to allow neutral support to both parties, to manage the scheme, 
overcome barriers and achieve KPIs. Future schemes would benefit from similar levels of 
complimentary management – business and clinical. 
There were high levels of success in implementation both where there were existing relationships, and 
where new relationships were developed. Recruitment was challenging due to limited supply of 
independent prescribing pharmacists in community pharmacy. As a result, one post was filled via a 
secondment of a hospital pharmacist. The scheme demonstrated that hospital pharmacist 
independent prescribers (IPs) as well as community based IPs can successfully transfer into patient 
facing primary care roles. Induction is vital to the success of the scheme. Typical induction periods 
covered 8 days whether this is 1 day per week or 4 days per week. Successful inductions included a 
period of clinical shadowing (with as wide a range of people as possible) and IT training. There is 
evidence that where no induction is provided this can create barriers to successful implementation. 
Mentoring is successful where scaffolding is provided from full support at induction withdrawing as 
confidence increases. Sites should be fully briefed of CPIP abilities and the front loaded investment 
time required in mentoring new posts to avoid mismatches in expectation.  
Capacity 
There is a wide range of ways that CPIPs can release capacity to the Primary Care team and contribute 
to managing demand. As soon as they are in post CPIPs can undertake medication reviews and 
respond to prescription queries which immediately releases GP capacity and thereby saving money for 
the practice. Through a scaffolded mentoring process CPIPs can begin chronic disease reviews in the 
early stages (within the first 6 months) of the role and be in a position to undertake them 
independently thereafter. This work releases further capacity and also generates income through the 
Quality and Outcomes (QOF) scheme. Practices can focus chronic disease work around local demand 
and respond to strategic needs. CPIPs who have been working for over six months, or who have 
experience of secondary care can support the primary care role in the discharge process. This work 
releases capacity, improves service and can have a significant impact on preventing readmissions 
therefore saving NHS spend in both primary and secondary care. The evidence collected clearly 
demonstrates the ways in which the work of the CPIP releases capacity for GPs and nurses. Improving 
capacity was a clear driver for the stakeholders in the scheme. The evidence supports the concept 
that CPIPs can have a positive impact on the current supply-demand issues in general practice. 
Quality 
CPIPs have demonstrated that they deliver holistic person-centred care, through longer appointment 
times and considering the patient and their range of conditions and medications as a holistic entity. By 
ensuring patients understand their medicines more, CPIPs can increase medication adherence which 
leads to more efficient and effective use of medicines which can have cost benefits. Finally the 
evidence has shown how CPIPs use motivational interviewing and monitoring to generate lifestyle 
changes in patients which could have long term impact for their wellbeing and reduce the longer term 
cost burden to the NHS. The evidence demonstrates the ways that CPIPs can offer a quality service 
to patients. 
‘Community Pharmacist Independent Prescribers’ (CPIPs) working in patient facing roles in Primary Care 
Independent Evaluation Report  University of Nottingham October 2017 
 
 
   3 
 
Uniquity 
This section has given examples of uniquity – the way that the expert knowledge skills and experience 
of the CPIP adds value to their role. Patients report increased satisfaction through management of 
medication reactions and interactions to minimise side effects. CPIPs can serve as an important safety 
barrier in primary care identifying and preventing adverse effects often from sub optimal medicines 
optimisation made by others. All stakeholders in the practice environment learn from, and benefit 
from, the unique medication knowledge held by the CPIP. The CPIP uses their unique knowledge to 
remove unnecessary medicines from repeat prescriptions which represent cost savings to the NHS. 
The CPIP can act as a conduit for information and prescribing practise from national guidelines and 
supported by local teams to practise cost effective prescribing. The evidence supports the concept 
that CPIPs have unique skills which add value in a unique wide range of ways to benefit patients, 
practice staff and the NHS at a broad economic level. 
 
 
 
Take Home Messages 
Implementation 
• Successful partnerships can be made between GPs and Pharmacists with no existing 
relationships 
• Where existing relationships exist between a practice and CPIP the work can develop faster 
than where no relationship exists 
• Recruitment – there may not be the ready supply of IP  anticipated and further upskilling of 
Pharmacists to IP status may be beneficial to the overall development of the sector 
• An induction period delivered locally is essential to building relationships, trust and 
development of the role  
• An 8 day induction period (prior to patient facing work) provides a good quality introduction 
to the new work context, creates a sense of belonging and trust and forms a solid base for 
mentoring and role development  
• An induction to general practice should include (as a minimum) the opportunity to shadow a 
range of staff, learn and practise working with the IT system(s), and build mentoring 
relationships 
• Mentoring is a significant initial time investment for GPs with benefits realised later on during 
the first year 
• Successful mentoring utilises a reducing scaffold model, often as per registrar training 
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Capacity 
• Medication reviews were conducted by CPIPs from day 1 releasing capacity from GPs 
• CPIPs visits to care homes and domiciliary environments represent a significant release of 
practice capacity 
• Prescription queries, both from patients and other staff, quickly become the responsibility of 
the CPIP improving capacity for other staff 
• Chronic disease management can be delivered by CPIPs including medication reviews and 
adherence and condition monitoring 
• CPIPs can be actively directed to follow the strategic direction of local practice needs in terms 
of condition management and prescribing 
• CPIPs positively contribute to discharge management and provide a strong link between 
primary and secondary care and the domiciliary or care home environment(s) 
• CPIPs can manage acute care consultations and provide a useful back up to others offering 
these appointments, especially as demand fluctuates 
• Patients recognise the benefits on primary care capacity and are happy to have ease of access 
to a clinician 
 
Quality 
• CPIPs were able to personalise appointment lengths according to the needs of the patients; on 
the whole CPIP appointments were twice as long as GP appointments or greater 
• CPIPs provide holistic care by considering the person as a whole system of conditions, 
medicines and personal circumstances 
• CPIPs provide invaluable medicines education and usage advice to patients 
• CPIPs medication advice to patients leads to increased medication adherence which has 
potential for positive health and cost saving benefits 
• CPIPs use skills in motivational interviewing to give advice about and monitor lifestyle changes 
which can have positive health an cost saving benefits 
• Patients are very satisfied with the expert medication knowledge and skills of the CPIP which 
has been proven to rectify problems others have not been able to 
• CPIPs can have positive impact on patient safety through their unique knowledge of 
medications 
• CPIPS work on medication understanding, adherence and safety can prevent patients’ 
readmission to secondary care which can save money for the NHS 
 
Uniquity 
• CPIPs bring unique expert knowledge to the primary care skills mix 
• Patients benefit from holistic care which can lead to increased patient satisfaction 
• CPIPs actively deprescribe and practise cost effective prescribing which has cost saving 
benefits for the NHS 
• CPIPs can act as a strategic tool to drive NHS or local health aims and objectives 
• CPIPs are able to conduct reviews and make interventions based on their expertise in 
medicines which may prevent hospital admissions 
• Patients recognise the unique benefits of the CPIP role and act as ambassadors of the role  
 
This report supports the concept that ‘CPIPs can play a positive role in general practice and have a 
positive impact at all levels - on patients, practices and the NHS’  
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Theory of Change Model 
 
The following theory of change model summarises the key learning from the data collected in this 
evaluation. 
 
Figure 1 Theory of change model observed from Community Pharmacist Independent Prescribers’ (CPIPs) working in patient 
facing roles in Primary Care evaluation 
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Background 
UK Primary Care Context 
The General Practice Forward View (GPFV) (NHSE, 2014) recognises some of the key issues in 
efficiently and effectively managing the frontline demand and supply of healthcare in the UK . The rise 
in long term conditions and the ageing population has impact on an increasing demand for Primary 
Care. GP consultations increased between 1996 and 2008 by an estimated 11%, and nurse 
consultations by 150% (GMC, 2016). At the same time spending on the NHS, and in particular in 
General Practice in Great Britain has declined. Furthermore there are significant reductions in the 
numbers entering general practice as a career, and a high rate of turnover of those working in the 
profession. (Baird et al 2016) 
In 2013 the Royal Pharmaceutical Society ‘Now or Never’ report (Smith, Picton, & Dayan, 2013) 
suggested a significant rethink of the models of care through which pharmacy is delivered, away from 
dispensing and supply, towards using the professional expertise of pharmacists.  The Royal College of 
General Practitioners (RCGP) agrees and suggests that primary care requires a more diverse skill mix 
and community pharmacy is a ‘significant unexploited potential’. (Gerada & Riley, 2012) 
This project was originated from the work of the Clinical Leadership Advisor / Controlled Drugs 
Accountable Officer at NHS England In July 2014. A business case was proposed to prove the concept 
that pharmacists situated in a general practice could provide a range of services and relieve some of 
the pressures on primary medical services. (Travis, July 2014) 
The work reported here focuses on this early scoping and proof of concept work. 
This pilot was very timely. The GP workforce 10 point plan (NHSE, 2015a) acknowledged that GP 
practices were recruiting pharmacists and laid out plans for a national pilot launching in 2015 with the 
first pharmacists working in General Practice on the pilot scheme by 2016 (NHSE, 2015b). This scheme 
is currently underway and evaluation taking place. The GPFV action plan (NHSE, 2017) confirms that 
this is seen as a long term solution and sets out that by 2020 there will be 10,000 more medical 
professionals working in general practice with a real term budget rises of up to 15%. 
Within this piece of work one GP participant summarised this  
‘The problem we have got is, for example, when I first came here we had 5000 patients, 
over the last 4 years we have now got 10,000 patients. The amount of doctors has stayed 
exactly the same so the number of sessions we have to fulfil that has stayed the same.  
We have done sit and wait so the number of people I see has massively increased but the 
funding, because they have bought in this thing called Fairer Funding which is a 
euphemism for cuts, means that actually our income has stayed the same. We have 
managed to hire a little bit more admin staff and an additional nurse and she is coming 
soon. But apart from that my take home pay will keep on reducing as it has done for the 
last 7 or 8 years. So doctors surgeries partners will only look at this if they have a 
vacancy I suspect, and they can’t fill a doctor’s slot.  If we had a doctor who went and 
we just couldn’t get a doctor for love nor money, then actually we would probably 
really do this because he is a prescriber and we would probably push a lot more minor 
illness and he would probably get lots of letters and we would want to see him consulting 
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a lot more. We had a vacancy recently and we offered partnership and we had one 
applicant! Lots of areas are having no applicants.’ (5016 GP5 Interview) 
 
Scheme Outline 
A business plan was written and funding approved by NHS England for a pilot of the new clinical 
pharmacy role over 18 months across one area of the UK. Two project managers were recruited to 
manage the scheme – one as a business manager and another as a clinical manager.  
As a ‘proof of concept’ study the work had a range of key aims including piloting: 
1. the role in a range of scenarios – in different sized practices, in different areas, with a range of 
part-time posts 
2. a part-time role where pharmacists remain connected to the community pharmacy context 
3. a range of patient facing activities determined by practice needs 
4. the role as an independent prescriber 
The pilot spanned one geographic region and five CCGs of variable size. Six general practices were 
recruited to the scheme, matched to six pharmacists for a period of one year. Funding was provided to 
the employing community pharmacy as ‘buy out’ costs for the 12 month secondment. Pharmacists 
worked for a varying range of hours in each practice, between one day and four days per week. Each 
site started at a differing point over 2015.  Generally practices and pharmacists were recruited 
independently and matched by the NHS commissioners, although one site and pharmacist were 
recruited who had an existing relationship and submitted a joint application. One pharmacist was 
recruited on secondment from secondary care. This differing range of scenarios allowed a unique 
experience to observe a health services implementation with some minor differences but one key and 
parallel aim – to prove the concept that prescribing pharmacists can become integrated and play a 
major role in supporting patients in primary care. Below shows a summary table of the sites at the 
commencement of their pilot. 
Site Size Sites No. of GPs 
Start date 
CPIP 
Days per week 
worked Prescribing status 
1000 Small 1 1 Sept 2015 / Oct 2015 1 day / 2 days IP 
2000 Medium 2 9 October 2015 2 days 
Supplementary 
Not prescribing 6m 
3000 Large 2 10 October 2015 3 days IP 
4000 Large 3 10 July 2015 / Oct 2015 2 / 4 days IP 
5000 Medium 1 7 
Nov 2015 /  
Feb 2015 / 
April 2016 
1 / 2 / 3 days IP  
6000 Large 4 16 April 2016 3 days IP 
Figure 2 Summary table of CPIPs and sites logistics. 
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One of the sites withdrew, therefore 5 sites completed the proof of concept pilot scheme.1 Every other 
site completed a minimum 12 months. 
One of the measures of the success of the scheme may be in the depth of concept proved. Of the five 
pharmacists who participated in the pilot scheme, 4 of them (80%) remain employed in the practice 
funded directly by the practice. This in itself is valuable outcomes data that evidences the concept 
worked and created added value for the pilot sites.  
Audit work undertaken by the scheme commissioners demonstrates the types of work undertaken. 
These are outlined at figure 2. Over half of the work undertaken by the new CPIPs was in medication 
reviews, a third related to reviewing long term conditions2 and their management and almost 10% of 
time was spent supporting general demand with urgent care appointments3.  
 
 
Figure 3 Types of appointments undertaken by Clinical Pharmacists in pilot proof of concept scheme (Reproduced from 
commissioner data) 
The observation data collected demonstrates that the average appointment by a CPIP was significantly 
longer than those by a GP or Nurse. First round observations showed wide ranging average 
appointment times from 15-75 minutes, this had reduced slightly by second round observations to 10-
40 minutes. 
The cost per consultation has been calculated by commissioners (by adding the Community 
Pharmacist costs with GP supervision costs and dividing that by the activity) ranging from £18.00 to 
£38.00. Early results indicate that the average cost per consultation is approximately £20 for CPIPs in 
this scheme (including GP supervision).  
                                                            
1 Clinical Pharmacist at site 2000 withdrew part way through the scheme due to personal reasons 
2 Long term conditions review includes - AF reviews, DMARDS, COPD, Asthma reviews, Anticoagulation reviews, Chronic kidney disease 
3Urgent care is defined as - Ear infections, Ear wax, UTIs, skin conditions, minor ailments 
 
48%
2%
31%
9%
10%
General Practice based medication reviews
Nursing Home or house Bound medication reviews
Long term condition reviews
Urgent Care
Other
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Methods 
 
The qualitative evaluation work commissioned to be undertaken by the University of Nottingham 
outlined a series of key questions relating to the operationalisation and outcomes of the pilot scheme. 
A full list of research questions is in Appendix A. 
An ethnographic approach was taken to this 
service evaluation with an emphasis on 
developing a detailed and situated understanding 
of how the intervention was organised, delivered 
and experienced in the context of different care 
settings. All six sites were visited for an initial 
meeting with key stakeholders. A second visit to 
each site was undertaken in which the CPIPs were 
observed undertaking consultations and semi-
structured interviews were held with key 
stakeholders in the practice. Observation data 
was also collected from CPIPs training courses, 
and stakeholder meetings. A third visit was 
undertaken, repeating the activities of the second 
visit, at a 4-5 month interval from that visit. A 
focus group was held with patients at each site.  
Ethical approval for the project was sought from the University of Nottingham Faculty of Medicine and 
Health Sciences Research Ethics Committee and confirmed that this project was service evaluation. 
Governance approval was also given locally from NHS England and representatives from all local CCGs 
areas involved in the study. 
The total data set from the one year evaluation utilised 75 independent sources of data collected from 
over 96 direct participants. Observational data was collected on at least ten separate occasions, 
covering at least 45 patient consultations. Interviews were conducted with 18 primary care staff and 
33 patients through 5 patient focus groups.  
Data was subject to interdisciplinary thematic analysis using emergent categories as well as the 
consolidated framework for implementation research.  
A timeline of site visits and observations and qualitative data collected was reported monthly and is 
included in Appendix B. 
  
 
 
Ethnography
Observations 
of 
consultations
Clinical 
Pharmacist 
interviews
GP and 
practice staff 
interviews
Patient Focus 
Groups
Desk research
Routine 
service data
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Findings 
 
The quantitative routine service data collected by pharmacists in situ, analysed and presented by 
programme managers (Ellis and Quinn 2017) aimed to provide numerical measure of the scheme. This 
qualitative research draws on the statistical data presented and seeks to explore and understand the 
implementation and outcomes of the project from the perspectives of multiple stakeholders.  
The findings section is split into two key areas: the early onset of the scheme – Implementation and 
the outcomes of the scheme. 
Implementation 
This section outlines the key findings of data analysis relating to the scheme implementation and 
these findings have useful implications for the rollout of any future schemes.  
Scheme Management 
The roles of the managers of the scheme, both from a business and clinical perspective, were key to 
the success of the scheme. The actions of the managers helped to overcome hurdles, drive a set of 
common but variable goals, and ensure the overall success of the scheme.  
At one site there were some significant barriers to the success of the scheme which were successfully 
navigated by the management team. This included personality differences between practice staff and 
pharmacist, changeover of local staff leading the pilot and clashes between the motivations of the site 
and the pharmacist. 
Without the scheme managers there would have been no-one providing hands-on oversight and 
tracking of the scheme to ensure that the rollout was live and successful. The managers had a crucial 
role in negotiating key deliverables with sites and tracking and analysing key performance indicators 
(KPIs). 
The project managers created a ‘community of practice’ including key stakeholders to drive forward 
learning from the project both across sites, and more widely across NHS partners. This was facilitated 
through local action learning sets, local monthly stakeholder meetings, and bi-monthly programme 
board meetings and wider dissemination through local and national networks including quarterly 
email updates to stakeholders. 
Recruitment 
Recruitment of community pharmacist independent prescribers to the available posts was more 
challenging than anticipated.  Recruitment approaches varied; one site applied in conjunction with 
their CPIP, building on an existing relationship, and others applying independently to form new 
relationships. There was evidence of successful pilots recruited in different ways.  
There were some difficulties in availability of CPIPs from community pharmacy resulting in recruitment 
of one pharmacist from secondary care. There was no difficulty in recruiting practice sites. Several 
practice sites indicated a preference for and benefits from being closely geographically located to 
community pharmacists’ sites. 
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Induction 
The majority of the sites had a minimum of 8 days spent on site focused on induction activities 
including shadowing key clinical staff and undertaking IT case based training. Two of the sites had 
existing relationships with their CPIPs and one of these as such selected a shorter induction period. 
Clinical shadowing was seen as crucial to the role and its ongoing development starting in induction 
and continuing through the placement.  Several days were spent at each site working on IT 
familiarisation; this was true even where CPIPs were familiar with the system but were now required 
to use it in a new way to record consultations, and whilst patient facing.  All sites developed inductions 
locally, supported by managers who sourced and provided additional training and support where 
required. At most sites this included personalised IT training. Those sites who developed a strong 
induction programme built strong relationships and a scaffolding mentoring relationship. One site did 
not provide an induction and this site suffered some ongoing difficulties with relationship building, 
trust and mentoring. 
Evidence suggests that a locally developed personalised induction scheme for CPIPs is vital to generate 
a sense of belonging and ground future relationships. This induction should last for 8 days or 
equivalent, regardless of the days and hours worked, and should include personalised IT training, 
clinical shadowing, relationship building with practice staff and strategic planning according to local 
demand. 
Mentoring 
Several of the sites work as GP training sites and have GPs who are active trainers familiar with the 
role of mentoring. Several sites reported transferring this approach to mentoring the pharmacist.  
The successful models of mentoring are built on clinical training models of scaffolding (Waters and 
Wall 2008) where much support is given at the start of a task and slowly withdrawn as independence 
in the task and confidence are demonstrated. Two examples of this mentoring in practice are outlined. 
At site 1000 the CPIP was mentored by the GP and initial scaffolding in the first weeks included 
reviewing every appointment and every action and prescription after each half day clinic. After the 
first two weeks this reduced to reviewing selected problematic cases daily, and after the first month 
this reduced to reviewing cases of the CP’s choice weekly with the GP. After one month the CPIP 
worked independently accessing mentoring informally on demand and formally once per month. 
At site 5000 the CPIP was given a list of 50 medicines that the GP was happy for him to prescribe 
unsupervised, anything the CPIP wanted to use beyond the list had to be approved by the GP. A similar 
method of consultation review to that described above also existed. Over a period of time the GP gave 
the CPIP further medicines and conditions to learn about and the list of medicines allowed to be 
prescribed was increased. Similarly the intensive mentoring was reduced from daily to weekly and 
over a period of time to an informal on demand model. 
There was some mismatch in expectation over the amount of mentoring required. Several GP mentors 
expressed a lack of awareness of pharmacist capability. GP5 recognised that the pilot was top loaded 
with investment likely to be realised at a later point. 
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Pharmacists will start off in a limited role and then as they get better, their 
competencies grow, there will be expansion. I think it has been very useful for us 
because it has allowed us to evaluate what can and can’t be done but it is early days. I 
think unfortunately NHS England will want instant answers but realistically you 
probably need to run it for a couple of years to know whether it is useful or not.’  
5015 CPIP Interview 
 
Summary 
The management roles were vital to allow neutral support to both parties, to manage the scheme, 
overcome barriers and achieve KPIs. Future schemes would benefit from similar levels of 
complimentary management – business and clinical. 
Recruitment was problematic due to limited supply of independent prescribing pharmacists in 
community pharmacy. There were high levels of success in implementation both where there were 
existing relationships, and where new relationships were developed. The scheme proved that hospital 
pharmacists IPs as well as community based IPs can successfully transfer into patient facing primary 
care roles. 
Induction is vital to the success of the scheme. Typical induction periods covered 8 days whether this 
is 1 day per week or 4 days per week. Successful inductions included a period of clinical shadowing 
(with as wide a range of people as possible) and IT training. There is evidence that where no induction 
is provided this can create barriers to successful implementation.  
Mentoring is successful where scaffolding from full support at induction withdrawing as confidence 
increases. Site should be fully briefed of the CPIP abilities and the front loaded investment time 
required in mentoring new posts to avoid mismatches in expectation.  
This section gives useful guidance about contributors to the successful implementation of the scheme 
that might be useful and transferable to other similar contexts.  
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Scheme Outcomes - Capacity 
Medication Reviews 
As previously reported from routine service data 55% of the CPIPs work was in undertaking medication 
reviews. All sites agree that medication reviews free up time from the GP or nurse that would have 
undertaken them. 
‘Yes probably because all the medication reviews would normally be seen by a GP.’  
6105 PM Interview  
This capacity release allows other practitioners to focus on areas with less medication focus. 
Medication reviews were observed at all sites at both the start and end of the pilot scheme. It was 
reported that 43% of all UK patients are on at least one medication and of those aged 75 or older over 
70% take three or more medications (Petty, Zermansky, & Alldred, 2014). Since all GP practices have 
to offer medication reviews to those on annual repeat prescriptions, the economic cost benefits of a 
specialist to deliver this service can easily be calculated.   
The Practice Manager at site 3000 saw the role as an opportunity primarily to increase capacity 
‘So we saw the community pharmacy project as an opportunity.  In terms of complaints, 
the majority of complaints that I get, are around appointment access with a clinician.  
So to alleviate that, we saw community pharmacists as an option’ 3205 PM3 Interview 
The Practice Manager feels this target was met simply by medication reviews 
‘He has been worth his weight in gold in terms of the medication reviews that he has 
taken off the GP’s.’ 3205 PM3 Interview 
They would continue with the role simply for this benefit.  
‘We want to have a look what works for us, and as you have heard today, the medicine 
management side is really making an inroad into freeing up GP time and more 
appointments time, they will want to have a continuation of that model’  3205 PM3 Interview 
Conducting medication reviews is something that all CPIPs felt confident to deliver from day 1 of the 
scheme.  GPs felt confident that this task exploited the CPIP’s expertise in medicines and mentoring 
through this task built confidence and trust for both parties. Patients supported this as a positive use 
of expertise 
‘It’s got to have been wonderful for the doctor and the rest of the staff, that somebody is 
there to deal with us as well instead of taking up other people’s time, you know, 
probably worse than we are.’ (Patient 1006 Data 1111 Patient Focus Group) 
 ‘It was extremely helpful but more importantly, the times that you are able to see [CP3] 
to discuss medication, you are not taking up a GP’s appointment.’ (Patient 3001 Data 3110 
Patient Focus Group) 
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All pharmacists conducted medication reviews both by telephone, and face to face, according to the 
needs of the practice, patients and strengths of the CPIPs.  By their sixth month all CPIPs were also 
delivering off site, domiciliary and care home medication reviews.  
The average length of a medication review varied enormously depending on the level of 
polypharmacy, patient demand and pharmacist confidence.  Time taken to conduct a holistic 
medication review usually exceeded the 10 minute slots which are allocated for GP consultations. The 
time taken to conduct medication reviews reduced over time. In early observations medication 
reviews took on average 30-60 minutes; in later observations this was 15-30 minutes. It is important 
however to emphasise that reviews always varied according to patient need. Although medication 
reviews by CPIPs took longer on average than those by GPs, they were in fact still more cost effective; 
commissioners calculated the cost per consultation of CPIPs in the local pilot scheme to be £20 on 
average. Given two key factors - that this cost includes early intensive scaffolding provided by other 
staff, and that CPIPs deliver the service faster later in the scheme, this is a cost that is likely to be 
decreasing over time.  
Having CPIPs conducting medication reviews saves money for a GP practice from day one. This is true 
even where mentoring support and/or referrals are required. The CPIP at site 2000 feels that his role 
significantly saves capacity for the GPs in the surgery, even if he sometimes has to make referrals.  
‘Say if you have got 10 patients and you have seen 8, and then only need to see the 2 
that need to... You know that you have saved that doctor those 8 appointments. All he 
patients I am seeing now, are not being seen by a GP or an ANP, and they are seeing 
more people on the day.’ (2103 CPIP Interview) 
This is supported by both the GP and Practice Manager at site 2000. The GP explains 
 “…we are a busy practice and we get behind with med reviews and lots of things. I think 
he has started doing quite a few asthma reviews too and that is all time that either a GP 
or a practice nurse would have spent doing so that would have been time freed up.” (2105 
GP Interview) 
From the improvements in capacity in the practice by month 6 of the pilot scheme PM has decided 
that the pilot is a successful proof of concept. 
Medication reviews conducted by CPIPs also add value in quality to the patient experience and these 
benefits are explored in the next section of the findings. 
Medication reviews add value to the primary care mix by releasing capacity from other staff who 
would otherwise complete medication reviews.  Patients recognise this benefit. 
I think your medication review that you have with the GP every 6 months, should really 
be done with the pharmacist, yes, because there is so many patients here everybody 
hasn’t had the opportunity to take up on that.  Ideally medication reviews, if they could 
come off the GP and give a bit of breathing space in the GP surgery but be done by 
someone, and not taking anything away, that is actually better at it.’ (Patient 4003 Data 4106 
Patient Focus Group) 
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Cost benefits are realised at all levels, especially in off-site reviews. By month 6 all CPIPs are 
undertaking medication reviews off site both domiciliary visits and care homes.  
Responding to the needs of care homes is a significant cost to primary care and various innovation 
models are being proposed to manage this demand efficiently. (NHSE, 2014, 2017) Since care homes 
patients aged over 75 are known to be three times more likely to be admitted to A&E (Oliver, 2016) it 
is clear that improving models of primary care support also have the potential to reduce hospital 
admissions. (NHSE, 2017; P. Smith, Sherlaw-Johnson, Ariti, & Bardsley, 2015) 
Data collected nationally in the UK by the Personal Social Services Research Unit shows that the cost of 
a GP undertaking a home visit in 2016 was £108 (Burns 2016). When compared to the calculated 
hourly costs for a clinical pharmacist working in general practice it is clear that CPIPs conducting this 
work instead of GPs represents a big cost saving for both the practice and the NHS.    
CPs were observed delivering off site medication reviews. One CPIP was observed working at two care 
homes. The CPIP was able to prescribe remotely at the care home sites using a SystmOne connected 
laptop with wireless connectivity provided providing a seamless service to care home staff and 
patients.  
CPIPs report that they enjoy conducting medication reviews which utilises their medications expertise 
and gives them experience in patient facing consultations.  However it is important to note that over 
time medication reviews can become tiresome for CPIPs who crave a wider work experience to 
maximise the potential benefits of their skills. It is therefore important that while medication reviews 
form a base for the CPIP work, they are not the mainstay or only beneficial use of pharmacists’ 
knowledge and skills.  
The Practice Manager at site 5000 discusses the benefits of an open service specification and the clear 
and scaled development plans which the practice had for the CPIP role, starting with medication 
reviews. 
 
‘Our main aim was for [CP5] to come in to do things like home visits and medication 
reviews for patients that were house bound.  So that was stage one, stage two was to 
do medication clinics, like 6 month reviews’ (5104 Practice Manager Interview) 
The total number of medication reviews conducted by the CPIPs on the pilot scheme as reported in 
routine service data as 55% of the total number of consultations; 2% of these were reviews 
undertaken in care homes or domiciliary locations.  
  
‘Community Pharmacist Independent Prescribers’ (CPIPs) working in patient facing roles in Primary Care 
Independent Evaluation Report  University of Nottingham October 2017 
 
 
  16 
 
Prescription Queries / Appointments 
The second work task that CPIPs were observed conducting from day one of their role is responding to 
prescription or medication queries from patients, colleagues across the practices and other colleagues 
off site including community based allied health professionals, community pharmacies and hospitals.   
This work is more difficult to measure economically since it does not require a fixed recorded 
appointment slot, or trackable record keeping. It is however something which was witnessed occurring 
at all sites from the onset of the scheme and something which many key stakeholders confirmed as a 
benefit of the scheme. One CPIP reflects on how GPs previously fitted in responding to prescription 
queries and how they have lifted some of this workload. 
 ‘Something I have noticed, the workload in terms of like the script queries, they have 
noticed when I have not been there which is good. And it’s those little bits, because 
obviously, the queries they do in between their clinics, they do clinic, they do the queries, 
they do the home visits, and back to clinics. They don’t have much time, so if it frees up a 
half hour slot then they are probably very grateful.’ (6109 CPIP Interview) 
 
CPIPs were observed giving advice based on their experiences in community pharmacy. One patient 
called her GP practice requesting a prescription for pain relief for a child with chicken pox. The CPIP 
was able to respond to the patient and give medication advice and direct the customer to the 
community pharmacy for free medication on a local minor ailments scheme (Pharmacy First) that the 
patient had been unaware of. These instances represent time saving for other clinical professionals in 
the practice and cost saving for the NHS. 
As confidence builds in the CPIP role queries come in from other key practice staff 
‘So I have had a few times when doctors have sent me messages saying they are unsure 
what drug to prescribe, they know they want to prescribe drug x but they don’t know 
whether it is available or that sort of thing.  They’ve also come back with queries saying I 
have tried this drug, is there another alternative?’ 
There is a clear value to the potential safety and improved care benefits of knowledge sharing in a 
multi-disciplinary team. This is a benefit which is impossible to quantify economically.  
 
Chronic Disease Reviews  
All sites utilised CPIPs to undertake chronic disease reviews with patients, overall these represented 
around a third of all patient facing consultations undertaken in the pilot scheme. Observations 
collected evidence of reviews and clinics targeting a wide range of chronic conditions including 
asthma, diabetes, and CKD. This both released capacity and generated practice income via the QOF 
scheme (Chew-Graham et al., 2013). At some sites, chronic disease reviews were run alongside 
medication reviews from day 1. At other sites these reviews were developed at a later stage. By month 
6 of their pilot all CPIPs were undertaking chronic disease reviews therefore both improving capacity 
and generating income. This work varied according to local demand and often mapped to QOF targets 
therefore hitting multiple economic targets by simultaneously both improving capacity and generating 
income for the practice. 
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 ‘So hopefully that, as we get to the end of the QOF year because that will take some 
work off our asthma nurse so we shouldn’t have as many asthma reviews, it will save 
more nursing appointments because they are not having to come in for their blood 
pressure check and that sort of stuff. Yes otherwise they would have seen the nurse or GP 
for their medication review.’ (6105 PM Interview) 
Practice staff understand that the CPIPs work on chronic disease management makes a significant 
impact on managing demand and releasing GP capacity.  Patients also demonstrate recognition of the 
benefits of the pharmacist role to managing chronic conditions. 
 ‘I am happy with it yes because it’s wasting time of the doctor, on a recall just to say if 
your blood pressure is ok, it seems a bit overkill. You know, the National Health Service is 
in trouble, they say they want the doctors to do more, the doctor can’t do more than 8-9 
hours a day.  I don’t know how many patients they are seeing now but there is a fine line 
to what they can do.  So anybody who can give them the help, taking off I wouldn’t say 
the easy but the more mundane jobs, it has got to be better for everybody.’ (Patient 6007 
Data 6110 Patient Focus Group) 
Patients also recognise the potential wider impact of chronic disease management on wider NHS 
systems 
‘I think as well if you have got long term conditions and people’s illnesses are much more 
complex, people are living so much longer, I think there is so much pressure on the health 
system, I think if pharmacists could alleviate some of that pressure by supporting or 
whatever.  Because it is not going to get any better, it is just getting worse. If by having 
a pharmacist, you can keep those people out of hospital, and avoid hospital 
admissions, it would be fantastic (Patient 1002 Data 1111 Patient Focus Group) 
CPIPs can clearly make a positive impact on the management of chronic diseases and their associated 
medications. This positive impact can improve access to primary care for patients and reduce demand 
on secondary care therefore saving money.  
 
Discharge Management 
At all sites, by the end of the pilot scheme, CPIPs began work on managing discharge medications. The 
majority of CPIPs started the development of the role in to discharge management in the second half 
of the scheme. At two sites, one with an existing relationship with their CPIP at the onset of the 
scheme and one with a hospital pharmacist, discharge management was conducted from an earlier 
point in the scheme.  
The management of the discharge process has significant impact on readmission rate (Howard-
Anderson, Busuttil, Lonowski, Vangala, & Afsar-manesh, 2016). The commissioner’s own data shows 
that the CPIPs pilot scheme potentially reduced avoidable secondary care admissions by around 8% 
saving the NHS a potential £710k per year. 
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Acute Care 
At all sites by the end of the pilot scheme CPIPs were able to contribute to the management of local 
acute and urgent care. Some CPIPs developed this work in the first half of the pilot but most 
developed this work over a longer period of time towards the end of the scheme. Overall around 7% 
of the CPIP work was in acute and urgent care.  
Examples of acute care appointments were wide ranging and included 
• Coughs, colds and sore throats 
• Chest and breathing difficulties 
• Head lice 
• Ear wax and hearing difficulties 
The Primary Care Foundation (Carson, 2009) reports that nationally approximately 100 million same 
day appointments are made; This represents approximately a third of all overall visits across 8000 
practices in England in one year.  This research demonstrates that CPIPs have the potential to make an 
impact on this area of demand in primary care. 
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Capacity Conclusion 
There are a wide range of ways that CPIPs can release capacity to the Primary Care team and 
contribute to managing demand. As soon as they are in post CPIPs can undertake medication reviews 
and respond to prescription queries which immediately releases GP capacity and saves money for the 
practice. Through a scaffolded mentoring process CPIPs can begin chronic disease reviews in the early 
stages (first 6 months) of the role and be in a position to undertake them independently thereafter. 
This work releases further capacity and also generates income through the QOF scheme. Practices can 
focus chronic disease work around local demand and respond to strategic needs. Patients are aware of 
problems in primary care and recognise the benefit of increased access to their practice as an output 
of the CPIP role. 
‘You know with the NHS, I don’t know if anyone watched the news, but there is a lot 
about how much it is costing the NHS. To be honest I got the impression there was a lot 
of waste reducing that could take place. I know it is harder on a bigger scale but I think if 
you can do it chunk by chunk and doctors are one of the areas.  Patients are moaning 
that they can’t get an appointment for a long time, then this actually shows that this is 
a positive way of dealing with that problem.  It is one of the major problems patients 
complaining can’t get an appointment whereas all of us has kind of highlighted, he has 
kind of offered an appointment very quickly.’ (Patient 5005 Data 5108 Patient Focus Group) 
CPIPs who have been working for over six months, or who have experience of secondary care can 
support the primary care role in the discharge process. This work releases capacity, improves service 
and can have a significant impact on preventing readmissions therefore saving NHS spend in both 
primary and secondary care. 
Overall the Practice Managers suggested the scheme was a successful proof of concept as it showed 
how pharmacists can fill the gap currently left by the GP supply-demand issue. 
‘I would certainly see that if we were ever in a position that we needed to recruit 
another GP, that we would certainly be thinking about recruiting a pharmacist first to 
add to that skill mix, particularly if on the day acute and management chronic disease, 
you know there is a huge role for pharmacy there, and I would almost say that I would 
lean towards a pharmacist rather than a nurse if I were recruiting. Because I think it is a 
definite unique role in terms of practice, it’s not a nurse, it’s not a GP, it’s unique, so I 
think if you are going to get the best benefit from having a skill mix you need to broaden 
that as widely as you can.  I think you know there is no mistaking the fact there aren’t 
going to be enough GP‘s in the system and they are going to end up very, almost 
consultants in a practice, you they are the top of the tree which people refer to for 
specific criteria and the rest of the workload is managed differently in the practice. I 
think if pharmacists have a true role going forward then there needs to be some further 
work in how they can meet the rest of the GP workload’ ( 5104 PM Interview).   
The evidence collected clearly demonstrates the ways in which the work of the CPIP releases capacity 
for GPs and nurses. Improving capacity was a clear driver for the stakeholders in the scheme. The data 
collected supports the concept that clinical pharmacists can have a positive impact on the current 
supply-demand issues in general practice. 
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Scheme Outcomes - Quality  
Holistic Patient Centred Care 
Feedback from all key stakeholders demonstrated high levels of quality in CPIP patient facing 
consultations. Routine service data demonstrates that CPIP appointments were twice as long as GPs in 
general and this is supported by research evidence which observed consultations lasting from ten 
minutes to over one hour (from the same as a GP to 6 times longer). Through longer appointment 
times CPIPs were observed giving ‘holistic’ patient care, able to consider the patient as a whole 
combination of conditions and medications rather than focusing on one condition and considering it in 
isolation.   
“They usually just concentrate on the bit that is causing problems; they don’t have time 
to do anything else.  10 minutes, they don’t have time. Like I say it was an hour.” (Patient 
3002 Data 3110 Patient Focus Group) 
Patients at every site reported positive experiences and significant benefits due to longer 
appointments.  
‘I didn’t feel any rush at all.  I could talk about everything and he could explain things.  
He took his time explaining absolutely everything.’ (Patient 3001 Data 3110 Patient Focus Group) 
Patients recognised the benefits of longer appointments with the CPIP compared to standard GP 
medication reviews or single condition consultations.  
‘Normally when you go to the doctors, they only look at that one issue that you have 
gone in with, they don’t explore others because they have got other patients to deal 
with, that haven’t got time.’ (Patient 5003 Data 5108 Patient Focus Group) 
I mean with my medication before, it was just a case of the doctor thinking oh yes she 
needs so and ‘so, adding it to the prescription. I never felt that they had time to look at 
the whole lot.’  (Patient 3001 Data 3110 Patient Focus Group) 
On multiple occasions CPIPs were observed undertaking ‘joint’ consultations between family 
members, or with elderly people and their carers. One CPIP was observed undertaking a consultation 
with an elderly couple and their middle aged daughter who cared for them ensuring knowledge was 
shared and reinforced. In the care home observations, patients (with capacity) were invited to consult 
with the pharmacist and their care staff and some chose to do so. CPIPs also worked closely with 
domiciliary and family carers who all gave positive feedback. 
‘It was actually a really long consultation, really thorough.  I think probably looked at my 
mum as a whole, even though she wasn’t there.  I actually felt that he knew my mum 
even though he didn’t.  When I say didn’t, he understood her medication and he even 
went through one of her blood tests with me.  Because she was taking ibuprofen, he 
actually said really she would be better with a gel because of it affecting her kidney 
function.’ (Patient 3002 Data 3110 Patient Focus Group) 
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Patients reported no concerns with an appointment with a CPIP and often reported preference for a 
longer appointment with a CPIP than a shorter appointment with a GP. 
“You were able to get some quality time with a clinician.  Because obviously with the 
GP’s you get 10 minutes and you try and squeeze everything into that.  With [CPIP4] you 
got about 20 minutes , or sometimes over 20 minutes and it was not just  with 
medication, it was to do with things like lifestyle issues, with the best will in the world, 
GP’s can’t tackle in 10 minutes.’ (Patient 4001 Data 4106 Patient Focus Group) 
This is reinforced by GPs who recognise the limitations of their current working systems 
‘I think (CPIP5) does go into details a lot more with that and he has certainly picked up on 
some patients, their GFR is not so good, they are on this medicine shall we change 
things? The quality is undoubted. I would absolutely say the pharmacist when it comes to 
medicines, partly that may be time, but he has looked at things and there is a quality 
element on top of that.’ (5103 GP Interview) 
 
Medicines Understanding and Adherence 
100% of patients surveyed by Programme Managers reported that they had a better understanding of 
their medicines as a result of their appointment with the CPIP.  
‘I think I have had some people come in who don’t know how to take their tablet.  So, 
they might have had some medication from the hospital and they were just a bit 
confused and unsure, the doctor at the hospital said take these tablets and then they 
have gone away and then gone oh what do I do? How do I take them, or what are they 
for, why am I taking these? I’ve explained the reasoning behind that.’ (3103 CPIP Interview) 
All CPIPs were observed in an educational capacity, filtering knowledge about conditions and 
medications to patients. 
‘She just went through each thing, one by one, asked me how it was working for me; how 
I felt about it and did I really understand what it was for, why I was taking it.’ (Patient 1001 
Data 1111 Patient Focus Group) 
CPIPs believe there is an educational role in relation to medication that their unique skills benefit the 
practice. Comments from his patients support this, 
 “I felt that he had a little bit more time than you generally find with the doctor. He was 
able to discuss how are you getting on with the tablets, are you taking them on a regular 
basis.  Because I was a bit haphazard a little bit with mine. I had a discussion about the 
importance of this so yes, I felt it was a little bit more of a one to one and not sort of ok, 
right, next. Do you know what I mean? (P3002) Yes like he was focused on me the entire 
time I was in the room and not sort of like right, ok there’s your prescription, bye.” (Patient 
3001 Data 3110 Patient Focus Group) 
The public health education role of the CPIP was observed as a cross cutting benefit through the 
medication reviews, chronic reviews and prescription queries. The CPIP at site 2000 reports on the 
benefits of also undertaking asthma reviews and using the opportunity to provide education 
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‘People that are not well controlled, so they are using their blue inhaler. They were using 
it ad hoc, fine, once or twice a month.  All of a sudden they are using it 3 or 4 times a day 
for about 3 or 4 months, so they are not in control, from being in control they have gone 
out of control. ‘Isn’t that normal?’ no it’s not and then step their treatment up. So will we 
add on a steroid inhaler, a preventer. Then that should prevent them from having more 
symptoms in the first place as well.  Other things that we have done today like device 
checking technique, that is really important. More patients than not are not using their 
devices correctly.  So they are not getting the drug into their body. So it’s not in terms of 
the medication not working, it is not being used correctly. So they are not getting the 
drug down, and before you try to change the therapy you just make sure that what 
they are doing now is correct first.  So try to do that first before moving on, so that’s 
really useful as well. The intervention on them is making a massive impact. The NHS is 
spending all this money on medications that are not being used correctly, it may as well 
not be given. The patient benefits, they are gaining control, they are not having to 
make all the appointments again because they are not in control again and again. 
Check their technique and they get the best out of their medication, so not having things 
added on.’ (2102/2103 CPIP interview / Consultation observation field notes) 
 
There was evidence of the longer and more holistic appointments with the CPIP offering education to 
patients that had not been previously possible in GP appointments. 
‘His advice to me, like I say I tend to bit and bob a bit with my tablets, wait for the pain 
to come and then take them, when I should be taking them regularly every day. I think he 
had got a diagram up on the screen to show me.  Because I had told previous doctors I 
just take them when I feel that I need to. And I have always been ok that’s fine.  But 
when he said you do know they will have better effect if you take them every day like 
they are prescribed to take. So I said well why would a doctor say it’s ok?  He showed me 
a diagram and said this is what will happen if you just take them as and when, it will 
ease it for a little bit, but if you take them regular then it stays in your body and it is 
there all the time.’ (Patient 5002 Data 5108 Patient Focus Group) 
 
This is supported by data from GP interviews  
 
‘Our patients have demonstrated that they do need time, they do need half an hour to 
explain what they are taking, and hopefully that will have results and that is good.’ (5103 
GP Interview) 
 
There is significant research evidence that increased medication knowledge leads to increased 
adherence (Horne & Weinman, 1999; Julius, Novitsky Jr, & Dubin, 2009). Several patients discussed 
improved adherence as a result of increased knowledge. One repeated case in point relates to public 
knowledge about statins. In several consultations patients were given advice to take the statin at 
night, which appeared to be information they had not had before.   
‘She said do take this at night because your body only produces cholesterol when you are 
asleep.  I didn’t know that.  A lot of people don’t know that.’ (Patient 3001 Data 3110 Patient Focus 
Group) 
Future research measures may include recording of patients’ medication adherence post-education to 
quantify the link. Interestingly patients gave examples of sharing examples of new knowledge in their 
own communities which has an immeasurable positive impact on public health. 
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‘My brother, who lives many many miles away from me, also takes the simvastatin.  One 
time when I was staying there with him, I saw him taking it in the morning.  I said ‘is that 
your statin? Because I recognised the colour of it.  He said yes, I said you shouldn’t be 
taking it in the morning, you should take it at night.’  (Patient 3001 Data 3110 Patient Focus Group) 
NHS England estimates that 5% to 8% of unplanned hospital admissions are due to medication issues. 
Often the full course of prescribed drugs is not taken because of a failure to monitor and properly 
encourage and instruct patients. This, in turn, imposes costs because conditions are not properly 
treated and become more serious. (Frontier Economics, 2014) This work to improve medication 
understand and adherence therefore can have both short term quality of life and health benefits for 
patients and longer term cost and economic benefits for the NHS overall.  
We observed holistic appointments offering the opportunity to increase patients’ knowledge and 
understanding of their medications; and patient reported data suggests that increased understanding 
leads to increased adherence.  Furthermore patients report that they act as medication information 
ambassadors and public health experts in their own communities and therefore the impact of the CPIP 
role on increased adherence in public health seems likely albeit immeasurable. This work to improve 
medication understanding and adherence therefore can have both short term quality of life and health 
benefits for patients and longer term cost and economic benefits for the NHS overall. 
 
Motivational Interviewing and Lifestyle Advice 
Observational data shows that the quality holistic consultations provided by CPIPs often included 
lifestyle advice. This advice usually extended beyond typical measures of height and weight towards 
measurements and discussions related to smoking, alcohol, diet, exercise.  This is a function which falls 
to the responsibility of primary care but is not often accommodated in standard GP appointments and 
therefore adds quality value to the CPIP service 
‘I think they probably don’t, I would like to think they don’t do it as well because they 
don’t have the time and they might not go into as much depth as I might do.  Maybe not 
necessarily that but more the angle that I approach it from really.  So, they have only got 
10 minutes, they might just check the patient hasn’t got any problems, they have got 
enough of the tablets and they are taking all their tablets and that might be it.  Whereas 
I would kind of explore a bit more, like smoking, drinking, exercise, diets as 
appropriate.’ (6103 CPIP Interview) 
 
Consultations were observed where lifestyle advice was given as routine, and in discussion with 
patients many expressed how they valued the opportunity to be given lifestyle advice. 
‘So he said I had got to make sure I had plenty of water, a litre of water a day.  The best 
way of making sure that you have it is get a bottle, just fill it up, and drink it through the 
day. He kind of explained that the counter effect it can have a bad effect on your kidneys, 
I didn’t really appreciate that before.  Then he just asked me about healthy lifestyle, do 
you eat good food and veg, do you exercise, smoking and drinking, that sort of thing.  
Sort of standard questions that he could give you advice which was the impression I was 
getting, to make sure you do the best for yourself. Again, it’s quite a good service isn’t 
it?’ (Patient 5005 Data 5108 Patient Focus Group) 
‘Community Pharmacist Independent Prescribers’ (CPIPs) working in patient facing roles in Primary Care 
Independent Evaluation Report  University of Nottingham October 2017 
 
 
  24 
 
Patients reported a number of changes in lifestyle following the advice of the CPIP. 
‘Yes I cut salt out, I’ve nearly cut chips out, I was eating too much bacon, too much 
processed meat like corned beef, ham, stuff like that. I’ve cut pastry out; he said do it so 
you have got to do it haven’t you? He said all that is adding up to your blood pressure, 
it’s adding up to your cholesterol , cut all that out and hopefully get it down.’ (Patient 5003 
Data 5108 Patient Focus Group) 
These lifestyle changes, whilst being difficult to ‘measure’ both the changes and their potential impact 
on the patient, it is clear that positive changes in lifestyle can clearly have a very positive impact on 
management of long term conditions – in particular CKD, diabetes and asthma.  
‘Only walking, no need to join a gym and pay fees.  That was it really so I just walk 
regularly half an hour each day, or more than that.  Just ensure that your intake, you are 
not overdoing it, I still go to the pub….they were things I already knew, he wasn’t telling 
me anything new, all he was saying was this would be best for you.  He knows I 
understand that.’ (Patient 4005 Data 4106 Patient Focus Group) 
Driving forward improvements in lifestyle CPIPs often used an approach of ‘motivational interviewing’ 
in the consultation to drive forward improvements. Many patients confirmed that lifestyle advice was 
not ‘new’ knowledge but the context of having the information delivered by a clinician in relation to 
their health was motivational.  
‘I mean I know what I should be doing before he talked to me, he just reinforced it’ (Patient 
1001 Data 1111 Patient Focus Group) 
Some advice given was reactive to patient health and on other occasions it was preventative and 
proactive.  
‘I will do it anyway, it is the point of I am in the recovery process really so obviously I 
knew I would have to do it, hearing it is good because it re-enforces that and makes me 
know I have definitely got to do it because blood pressure runs in my family, strokes runs 
in my family.  So that just re-enforced it really it was good to have somebody actually 
tell you.’ (Patient 4006 Data 4106 Patient Focus Group) 
Some CPIPs routinely delivered lifestyle advice in every appointment and others personalised the 
delivery of lifestyle advice according to the specific patient needs.  
Several patients across different sites gave examples of where lifestyle advice from CPIP consultations 
motivated them to action. 
‘I lost 1½ stone in weight and also increased my exercise.’ (Patient 4006 Data 4106 Patient Focus 
Group) 
‘And it [BP] has gone down a lot. Yes I have to fasten my belt another hole! I don’t get 
out of breath so much now.’ (Patient 5003 Data 5108 Patient Focus Group) 
One patient reported stopping smoking after fifty years, on the advice, and with the ongoing support, 
of the CPIP in the GP practice.  
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One CPIP feels strongly that contribution to positive public health should be a key driver for the NHS 
and should use the CPIP role as a channel for health education 
‘So screening services, health checks, healthy living, these are the top 5 {conditions}, that 
are causing the biggest problems.  So just hit the top 3 or top 5. Health education is 
improving the uptake of medication, they know what they are doing AND they will 
support lifestyle changes along with the medication.  NICE guideline tells us to identify 
patients for education. Everyone must have health education, but how many actually 
have it? Only 2%!’ (5105 CPIP Interview) 
 
This CPIP builds lifestyle advice into every consultation and uses motivational interviewing (in which he 
has had prior training) to motivate patients to commit to positive changes. This includes advice and 
guidance on smoking cessation, alcohol reduction and management, weight and portion management 
and increasing exercise.  The CPIP utilises a personalised approach and self-devised materials to 
encourage ALL patients to commit to small stepped changes in their lifestyle to improve their health. A 
copy of the materials used are held at Appendix C.  
Recent estimates suggest that smoking alone costs the NHS £2bn and the economic benefits of the 
CPIP work in positive lifestyle changes could clearly have long term measurable impact for patients 
and for the NHS. 
 
Quality Conclusion 
This section has demonstrated the ways that CPIPs deliver holistic patient care, through longer 
appointment times and considering the patient and their range of conditions and medications as a 
whole interacting system. By ensuring patients understand their medicines more, CPIPs increase 
medication adherence which leads to more efficient and effective use of medication and can have cost 
benefits. Finally data has shown how CPIPs use motivational interviewing and monitoring to generate 
lifestyle changes in patients which could have long term impact for their wellbeing and reduce the cost 
burden to the NHS. 
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Scheme Outcomes - Uniquity 
 
Uniquity emerged as a key theme from the research data collected. In this category fall examples of 
where the unique skills and expertise in medicines held by the CPIPs benefit the patients, practice and 
Primary Care. These benefits can be seen through the examples given which also offer benefits of 
increased capacity and quality, but through the unique skills of the pharmacist. This is surmised by one 
of the supervising GPs. 
 ‘I think [CP5] does go into details a lot more with that and he has certainly picked up on 
some patients, their GFR is not so good, they are on ‘this’ medicine, shall we change 
things? The quality is undoubted. I would absolutely say the pharmacist when it comes to 
medicines, partly that may be time, but he has looked at things and there is a quality 
element on top of that.’ (5103 GP Interview) 
Research data show a wide range of examples of the unique value added by the CPIPs. These can be 
broadly categorised into increased patient satisfaction and increased patient safety, wider knowledge 
within the primary care MDT team, and the opportunity for deprescribing. 
 
Increased Patient Satisfaction 
The research data shows many examples of CPIPs using their expert knowledge of medications, 
medicine interactions and potential side effects to adjust medication dosage or usage advice for the 
benefit of the patient having positive impacts on their quality of life. 
One carer having a medication review on behalf of her mother who has Parkinson’s disease reported 
an increase in quality of life from simple medications use advice  
‘She wears a patch, for her Parkinson’s. He said does she have any problems with that? I 
said the only problem she has, she gets a rash. And he said well how you get rid of that is 
that before you put it on, just leave the air to it for 2 minutes, because it allows the 
solvent to evaporate, and then put it on.  My mum can’t believe it, because it has not 
itched and she has had it for years.  It has drove her absolutely mad.’  (Patient 3001 Data 3110 
Patient Focus Group) 
One patient attending for an acute appointment due to musculoskeletal pain was advised to stop 
taking the ibuprofen advised by others due to an awareness of the interaction with stomach 
medication also being prescribed. This resulted in reduced symptoms of stomach pain for the patient, 
which although present was a secondary presentation in the consultation and it is therefore unlikely 
would have been picked up by another clinician.   
One middle aged female diabetic patient expressed ongoing symptoms of painful, sore and swollen 
eyes. She had visited the nurse on multiple occasions that had been unable to rectify the problem. This 
had been ongoing for a long period of time and as a result she had stopped wearing make-up, become 
less confident and went out less often. The pharmacist recognised an adverse interaction between 
several medications and was able to represcribe and eradicate the life limiting side effects. The patient 
was emphatic about the benefit of the CPIPs expertise. 
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One CPIP reported an issue from a care home 
“…at times the patient becomes agitated and wanders round upsetting others. She 
doesn’t have dementia, she is in the home because she is frail. She has diazepam for 
agitation and it’s a controversial area because it’s a chemical cosh really. She takes it 
herself, so she consents to take it. They were giving her half a tablet and it was zonking 
her out. The son had been to visit her and she spent most of the time drowsy. They had 
only used occasionally, three times in 4 weeks, but naturally her son was unhappy. Then 
they explained and all agreed it is a good idea as she was a danger to herself and 
upsetting others who were then threatening towards her. I improvised a little, it is 
soluble in water so I suggested we dissolve it in 10 mls and then give her a bit at a time 
so you can control the agitation but she is not completely zonked. We also spoke about 
her diet because she has lost weight.” (3103 CPIP Interview) 
Each of these examples show ways that adjustments made to medications prescribed or advice about 
their usage had positive impacts on the lives of patients and carers in a wide range of settings.  
While these examples are impossible to quantify in terms of economic benefit, each offers a useful 
understanding of the tacit and immeasurable ways the expertise of the CPIP can have far reaching 
positive impact on patient experience in Primary Care.  
 
Increased Patient Safety 
The above examples all show reductions in small scale side effects and their positive impact on patient 
health and wellbeing. There are further examples where the role of the CPIP has avoided potential 
larger scale impacts which could have had an adverse impact on patient safety. On some occasions the 
CPIPs were observed rectifying prescribing or dispensing issues which may have had adverse effects 
patient safety. 
There is evidence that one key area of the unique expertise of the CPIP is their process of safety 
checking of medicines through the usual consultation process. The following example in an extract of 
field notes from an observation of the CPIP at site 4000 shows preparation for a medication review 
and shows the safety reviews that the CPIP was observed undertaking in a normal polypharmacy 
medication review.  
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Female patient, 59, 16 items prescribed - multi comorbidities.  
This includes recurrent UTIs, blood issues, CKD, osteoporosis, overweight, 
thyrotoxicosis, angina, BP issues. 
I want to check she has no GI problems as she is on aspirin, it’s a high 
dose so I’ll talk about diet and calcium. Propylthiouracil can cause 
problems with blood disorders so I want to a make sure she knows the 
side effects.  I don’t know why she is on it, they tend to use carbimazole, 
perhaps she reacted to that at some point. 
CPIP googles the medicine, then looks in the BNF, he explains he is 
looking for liver problems as a side effect.  
I don’t want to scare them to death but they do need to know things to 
watch out for. 
She is on risedronate, I’ll have a look how long because some of these 
people should be reviewed after 5 years. Ah next year will be her review, 
she has been on it since 2012. She should have had a bone scan in August 
last year but didn’t so I will talk to her about that. I’ll check she has had 
her bloods done recently. Yes liver check in the last year so that is fine. 
Kidneys aren’t bad and urea is up a bit but that just shows she doesn’t 
drink enough water. 
 
Figure 4 CPIP4 Preparation for medication review (safety check) 
 
Further examples from other CPIPs show that safety checking is a unique skill common to all the 
pharmacists.  
CPIP took a prescription query; telephone call was received by site 4000 from patient who had been 
prescribed antibiotics (and they were dispensed and in hand) but was worried about potential side 
effects. During the telephone consultation the CPIP realised that the patient was schizophrenic and 
that psychosis was a potential side effect of the medication prescribed so she was able to immediately 
change the prescription to one with less side effects, and made it available for the patient to collect 
from the practice immediately. In doing so she saved the patient from a potential adverse reaction, 
which could have had a further long term impact on her overall recovery, and responded to an error 
made by another professional  which could have otherwise impacted patient safety and had a liability 
cost.  
An observation of a CPIP conducting a domiciliary medication review for a patient recently discharged 
from hospital showed the importance of regular medication checks for the safety of elderly patients 
cared for in their own home. The patient was being given medication by care staff five times per day 
which she indicated caused her discomfort and the CPIP was able to reduce the medication 
administration to twice per day, reducing both  the overall number of tablets to be taken and the 
frequency. When probed about her use and storage of medication the patient revealed a bag of 
unused medicines which she was keeping ‘just in case’ but which she willingly passed to the CPIP for 
her to safely destroy. Within the bag was a large number of paracetamol in a range of doses, tramadol 
(which is no longer taken by the patient) and nortriptyline, some of the medicines being 3 years out 
of date. The potential adverse side effects of these medicines being taken in error by the patient or 
another are high risk. 
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Another CPIP reviewed a case where they had given telephone advice to care home staff about 
medication for a patient who was an alcoholic with psychological problems presenting with a range of 
side effects. The pharmacist visited the Care Home to conduct a face to face medication review with 
the patient and carer and discovered that the medication dosage prescribed for the patient was toxic 
and needed to be changed urgently. This incident happened on a Friday evening at 4.30pm just before 
Christmas. The CPIP was able to use their unique skills and previous experiences in community 
pharmacy to ensure the urgent issue could be resolved before side effects worsened. It is likely that 
this action prevented an unnecessary hospital admission over the Christmas period.   
‘My familiarity with the medication supply and whole MDS [monitored dosage system] 
meant I was able to sort this out before the holiday break.’  (4101 CP4 observational field notes) 
These few examples represent many others observed and recalled through the evaluation.  
 
Practice staff recognised these benefits and their potential impact on the business of Primary Care. 
The Practice Manager at site 4000 identifies many ways in which the unique skills of their CPIP add to 
the practice portfolio right from the outset of the scheme. 
“Improved risk management – in the first week she picked up someone who should be 
on warfarin but it had been missed.’  (1102 PM Interview) 
The longer term risk of the patient not being prescribed the appropriate medication has a life 
threatening impact and while this is unquantifiable economically, patient safety it is of clear benefit to 
the patient, the practice and the NHS. 
The cost of adverse side effects and sub-optimal prescribing to the NHS annually is estimated to be 
around £5billion. (Frontier Economics, 2014). A recent prospective cohort study has shown that, 
within 4 weeks of receiving a primary care prescription, 25% of patients experience an adverse drug 
event, 11% of which are judged preventable (Avery, 2002). While the independent cost saving by 
pharmacist or this pilot is difficult to quantify without further longitudinal individualised data, it is 
clear from the few examples shown that this role maximises safety and has positive impacts which 
have wide economic benefits for the NHS.  
These sections have demonstrated the impact of the pharmacist unique skills, knowledge and 
experience and the ways these have positive impact on patient satisfaction and safety. Examples have 
been shown of the ways that CPIPs checking medicines use and adherence, resolve side effects and 
interactions, and resolve prescription and dispensing errors generated by others.  
 
Expert Knowledge to the Practice and NHS 
Examples of the ways in which the expert knowledge held by the CPIPs benefit the practice have been 
shown in previous sections where, for example, prescription requests and queries are triaged towards 
the pharmacist and also where GPs check their own medication knowledge with the pharmacist. Data 
shows that at practice 4000 prescription and medication queries are presented to the pharmacist by 
the full range of clinical colleagues associated with the practice including GPs, Nurses, Healthcare 
associates and community staff such as care home clinicians and district nurses. Further examples of 
knowledge sharing reported in the data include CPIPs contributing to GP and practice meetings and 
written staff updates with important medication advice, including NICE updates. The benefit of the 
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expert knowledge of the pharmacist on the primary care knowledge and skill mix was valued by all key 
stakeholders in the research. 
Practice Managers demonstrate understanding that there is a unique role for the pharmacist and their 
expert knowledge in primary care in a way that can benefit patient care by adding valuable expertise 
to the MDT.  
“I think it is a definite unique role in terms of practice, it’s not a nurse, it’s not a GP, it’s 
unique, so I think if you are going to get the best benefit from having a skill mix you need 
to broaden that as widely as you can.” (2104 PM Interview) 
‘Yes because I think the pharmacist is an expert in medication.  They know far more than 
the GP’s do obviously it’s their field.  For the practice as a whole, it’s another expert in 
there.’ (5103 GP Interview) 
 
A GP from practice 5000 concurs and emphasises the benefit of the pharmacists’ shared knowledge as 
support to the GP in their complex prescribing role and the way in which this can have wider long term 
benefits including patient safety. 
 
‘With the medication, because it is really important, especially with medication mistakes, 
with discharge summaries coming back from the hospitals.  Obviously the doctor is 
ultimately responsibility for putting new meds on, for changing them; lots of patients are 
on anti-coagulant meds, warfarin, lots of complicated, lots of shared care schemes.  So I 
think there is a need, there is definitely a need there,’ (5103 GP Interview) 
 
Several GPs report that learning in the scheme is two way. The GP at site 1000 identifies that he 
benefits from mentoring the CPIP. 
‘Feedback sessions with her have been useful to date, both parties benefit. She queries 
anything she is not sure of and then I learn things from her as well, pharmacology wise.’ 
(1105 GP Interview) 
 
Several of the CPs report that they feel valued by the recognition that GPs uses their initiative unique 
knowledge of medicines to supplement their own learning for the benefit of the patients and the 
practice. 
 
‘So I have had a few times when doctors have sent me messages saying they are unsure 
what drug to prescribe, they know they want to prescribe drug x but they don’t know 
whether it is available or that sort of thing.  They’ve also come back with queries saying I 
have tried this drug, is there another alternative?’ (6107 CPIP Interview) 
The CPIP in site 6000 believes that the ultimate benefit of his role lies within his unique 
expertise 
‘I think it is working in the multi-disciplinary team and that extended working.  Utilizing 
our skills in primary care where GP’s and nurses might not necessarily have that 
expertise.’ (6107 CPIP Interview) 
 
One patient reported the way that the CPIP worked in tandem with the GP to manage tachycardia by 
adding expertise in monitoring the condition and making adjustments to medication. The patient 
recognised the benefit of the CPIP expertise on the workload of the other practice staff.  
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‘It’s got to have been wonderful for the doctor and the rest of the staff, that somebody is 
there to deal with us as well instead of taking up other people’s time, you know, 
probably worse than we are.’(Patient 5005 Data 5108 Patient Focus Group) 
 
The data collected shows that the unique knowledge and skills held by the CPIP in their patient facing 
role also benefit the wider practice staff. The role acts as a valuable channel for ensuring vital medical 
information is shared from NICE throughout general practice and to patients for their ultimate benefit.  
 
Deprescribing Opportunities 
Routine service data shows that medicines were stopped by CPIPs in 22% of cases as they were not 
being taken or no longer necessary. This is underpinned by evaluation data with examples from 
practice where CPIPs save money on the prescribing budget in a number of ways. Several examples 
already given demonstrate reduction in numbers of medicines prescribed and removal of over 
prescribed items present examples of cost saving. Several of the CPIPs report feeling responsible for 
contributing to cost effective prescribing.  
 
The CPIP at site 6000 feels that in day to day practice through good quality medication reviews there is 
often the opportunity to reduce unnecessary medicines therefore saving money for the NHS. 
 
‘I think getting rid of medicines off repeat prescriptions that people don’t really tend to 
use anymore because you all tend to get into the habit of just ticking every drug on the 
list but they don’t necessarily need really.’ (6107 CPIP Interview) 
Evidence from the literature reports that while overprescribing or prescribing errors may not always 
result in “adverse events”, they may result in unnecessary expense (Frontier Economics 2014). CPIPs 
clearly have the opportunity to practice cost effective prescribing habits which benefit the NHS on a 
day to day basis.  
Several observations of medication reviews demonstrate CPIPs reducing or withdrawing unrequired 
prescriptions for (or doses of) paracetamol, aspiring, tramadol, laxatives and barrier creams. The CPIP 
at site 4000 was observed with a 69 year old patient who has been prescribed a branded drug by the 
GP and is moving her to the generic version of the drug. Each of these small savings in cost effective 
prescribing contributes to a much larger overall saving for the NHS.  
National or regional changes to prescribing practices in primary care can be driven through the CPIP 
role. The CPIP at site 4000 reports using new NICE guidelines to drive her work resulting in both 
patient health benefits and cost saving for the NHS. She reports that NICE bought out new advice on 
anticoagulants and this filtered through to the Medicines Management Team at her local CCG. They 
provided her with a list of patients with AF at her practice meeting and set range of criteria including 
those not on any medication, or not on the new recommended ones or one another type which no 
longer met the guidelines. This represented a measurable cost saving exercise against the local 
prescribing budget and benefitted patients through improved monitoring and management of their 
condition.  
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Whilst deprescribing remains an important role, and was recognised by CPIPs, they are keen that this 
is not used as a measure of their practice in isolation from context. CPIPs recognise that their primary 
aim is patient centred care and that in some contexts this is incongruent with deprescribing practice. 
Overall deprescribing remains an important part of the CPIP role and represents an area of significant 
economic benefit to the NHS on a strategic and economic level.  
 
Patient as Ambassadors of the Scheme 
Patients clearly recognised the unique benefits of the CPIP role.  
‘Efficiency, cost saving in terms of the fact that you have got doctors time can be used on 
other people. You have got more happier patients by the sound of it, everyone has got 
quite good things to say which is improvements in service and customer care’ (Patient 5005 
Data 5108 Patient Focus Group) 
Patients had ONLY positive things to say and were actively acting as ambassadors for the service 
 ‘I have mentioned it to quite a few of my friends up and down the country, they haven’t 
got one, and they say ‘oh that’s a good idea isn’t it?’ So other people can see the benefits 
of it (Patient 4002 Data 4106 Patient Focus Group) 
Some patients were interviewed who had not experienced the CPIP service for themselves. One 
patient spoke positively about the service from word of mouth experiences. 
 “…it very quickly became known within the local community that there was a 
pharmacist there.  Because people felt they were going away with something good. I 
live in the community, I have worked in this community for 30 years so I know a lot of 
people, and a lot of people were saying oh the pharmacist is good….And I went oh good, 
what is happening, what are you liking about it?  Oh you get a 20 minute appointment 
up at the doctors!  People were saying they understand the medication more, they 
know why they are taking it.  Some of them had come away saying I don’t have to 
take such and such anymore.  I am not saying every single person has been elated by it 
but my first introduction of it was it is really good and that is from outside on the street.” 
(Patient 5005 Data 5108 Patient Focus Group) 
Patients recognised the unique benefits of both the CPIP role and the pilot scheme as an innovative 
development in primary care. 
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Uniquity Conclusion 
This section has given examples of uniquity – the way that the expert knowledge skills and experience 
of the CPIP adds value to their role. Patients report increased satisfaction through management of 
medication reactions and interactions to minimise side effects. CPIPs serve as an important safety 
barrier in primary care preventing adverse effects often from medication errors made by others. All 
stakeholders in the practice environment learn from, and benefit from, the unique medication 
knowledge held by the CPIP. The CPIP uses their unique knowledge to remove unnecessary 
medications from repeat prescriptions which represent cost savings to the NHS. The CPIP can act as a 
funnel of information and prescribing practice from national guidelines and supported by local area 
teams to practice cost effective prescribing. The CPIPs add unique value in a wide range of ways to 
patients, practice staff and the NHS at a broad economic level. 
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Theory of Change Models 
 
The data gathered during this evaluation has be used to create diagrammatic representations of the 
implementation of the CPIP pilot. 
There are two models, one which outlines the implementation of this pilot scheme and the second 
theory of change model summarises the key learning from the project that might have transferability. 
The difference between the two models shows the usefulness of the data collected in this evaluation 
and how it might usefully inform implementations going forward.  
 
Figure 5 Theoretical change model created from the original design of the ‘Community Pharmacist Independent Prescribers’ 
(CPIPs) working in patient facing roles in Primary Care’ pilot scheme. 
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Figure 1. Theory of change model observed from Community Pharmacist Independent Prescribers’ (CPIPs) 
working in patient facing roles in Primary Care evaluation 
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Conclusion 
 
This report shows that the pilot successfully evidences the assertion ‘CPIPs can play a positive role in 
general practice and have a positive impact at all levels - on patients, practices and the NHS’. This 
evaluation has outlined the ways in which the scheme was operationalised and highlighted the 
positive outcomes on multiple levels. Data has been provided from all key stakeholder perspectives to 
understand, explain and underpin the key findings.  
Of the six CPIP innovators who took on the pilot role, one had to leave the scheme part-way for 
personal reasons and another returned to their original post at the end of the scheme. Four of the six 
pharmacists were offered continuing employment in their primary care role by their practice site. 
This is a clear indication that during the one year scheme the CPIPs successfully proved their value to 
the practice hosts who chose to employ them directly. 
Patients showed overwhelming positive support for the role and their reactions demonstrate the 
concept of a CPIP in primary care is a valid useful role. Patients now actively seek out the CPIP as an 
alternative to the GP. 
 “I didn’t bother to make the appointment with (GP), when I rang I said I will make it with 
[CPIP].  I knew straight away she would be able to do it.” (Patient 1006 Data 1111 Patient Focus 
Group) 
Patients demonstrated that their familiarity with the new role was creating differentiation in the 
primary care skills mix, benefitting their experience and access to primary care. 
“I feel that [CPIP2] has enabled me not to have to go to the GP. If there is any problem 
with my medication I go to [CPIP2] I don’t go to the GPs. “(Patient 1001 Data 1111 Patient Focus 
Group) 
The theory of change model outlined above and derived from the learning in this pilot scheme can be 
used in moving forward with implementation schemes for Pharmacists working in General Practice. 
All key stakeholders reported very positive experiences from the pilot scheme. Much credit should be 
given to the innovative clinicians, general practice and CCG staff whose drive, commitment and 
enthusiasm was witnessed throughout the project and was clearly linked to its successful outcome.  
The take home messages that follow summarise the key learning from this evaluation. 
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Take Home Messages 
 
This report provides evidence to support the concept that - ‘CPIPs can play a positive role in general 
practice and have a positive impact at all levels - on patients, practices and the NHS’. 
 
Implementation 
 
• Successful partnerships can be made between GPs and Pharmacists with no existing  
relationships 
• Where existing relationships exist between a practice and CPIP the work can develop faster 
than where no relationship exists 
• Recruitment – there may not be the ready supply of IP  anticipated and further upskilling of 
Pharmacists to IP status may be beneficial to the overall development of the sector 
• An induction period delivered locally is essential to building relationships, trust and 
development of the role  
• An 8 day induction period (prior to patient facing work) provides a good quality introduction 
to the new work context, creates a sense of belonging and trust and forms a solid base for 
mentoring and role development  
• An induction to general practice should include (as a minimum) the opportunity to shadow a 
range of staff, learn and practise working with the IT system(s), and build mentoring 
relationships 
• Mentoring is a significant initial time investment for GPs with benefits realised later on during 
the first year 
• Successful mentoring utilises a reducing scaffold model, often as per registrar training 
 
 
Capacity 
 
• Medication reviews were conducted by CPIPs from day 1 releasing capacity from GPs 
• CPIPs visits to care homes and domiciliary environments represent a significant release of 
practice capacity 
• Prescription queries, both from patients and other staff, quickly become the responsibility of 
the CPIP improving capacity for other staff 
• Chronic disease management can be delivered by CPIPs including medication reviews and 
adherence and condition monitoring 
• CPIPs can be actively directed to follow the strategic direction of local practice needs in terms 
of condition management and prescribing 
• CPIPs positively contribute to discharge management and provide a strong link between 
primary and secondary care and the domiciliary or care home environment(s) 
• CPIPs can manage acute care consultations and provide a useful back up to others offering 
these appointments, especially as demand fluctuates 
• Patients recognise the benefits on primary care capacity and are happy to have ease of access 
to a clinician 
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Quality 
 
• CPIPs were able to personalise appointment lengths according to the needs of the patients; on 
the whole CPIP appointments were twice as long as GP appointments or greater 
• CPIPs provide holistic care by considering the person as a whole system of conditions, 
medicines and personal circumstances 
• CPIPs provide invaluable medicines education and usage advice to patients 
• CPIPs medication advice to patients leads to increased medication adherence which has 
potential for positive health and cost saving benefits 
• CPIPs use skills in motivational interviewing to give advice about and monitor lifestyle changes 
which can have positive health an cost saving benefits 
• Patients are very satisfied with the expert medication knowledge and skills of the CPIP which 
has been proven to rectify problems others have not been able to 
• CPIPs can have positive impact on patient safety through their unique knowledge of 
medications 
• CPIPS work on medication understanding, adherence and safety can prevent patients’ 
readmission to secondary care which can save money for the NHS 
 
Uniquity 
 
• CPIPs bring unique expert knowledge to the primary care skills mix 
• Patients benefit from holistic care which can lead to increased patient satisfaction 
• CPIPs actively deprescribe and practise cost effective prescribing which has cost saving 
benefits for the NHS 
• CPIPs can act as a strategic tool to drive NHS or local health aims and objectives 
• CPIPs are able to conduct reviews and make interventions based on their expertise in 
medicines which may prevent hospital admissions 
• Patients recognise the unique benefits of the CPIP role and act as ambassadors of the role  
 
This report supports the concept that ‘CPIPs can play a positive role in general practice and have a 
positive impact at all levels - on patients, practices and the NHS’. 
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Appendices 
 
Appendix A  Full list of research questions 
Appendix B  Site visit and data collection schedule 
Appendix C  Materials used by CPIP to support patient lifestyle changes 
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Appendix A 
 
The proposed formative evaluation addresses a number of key developmental questions that will 
assist the future roll out of the initiative:  
 
1. What is the underlying theory or model of change on which the initiative is developed, what 
forms of evidence or experience have been influential and how can a refined model of change 
be used to inform future measurement and summative evaluation? 
2. How does the initiative move from concept to specification to practice, with particular 
attention to the influence of key decision-makers, patient co-design and local service leaders? 
3. How are CPs integrated into local GP practice arrangements, with particular attention to the 
local contextual factors, e.g. resource profiles, occupation and organisational boundaries; 
leadership, service cultures, established ways of working, IT and other technological 
capabilities? 
4. How is the service organised and delivered in the different pilot sites as a ‘situated’ 
intervention, with particular attention to the local changes in practice and the influence of 
wider contextual factors, as detailed in question 3? 
5. How do different stakeholders perceive and experience this new service configuration, 
including GPs, CP, patient and family members, practice managers, practice support staff and 
other community based healthcare professionals? 
6. What evidence can be found, primarily qualitative, but also from routine service data, that the 
pilot has brought about change in the management and delivery of primary healthcare, with 
particular attention to the developed model of change including assessments of GP workload 
and time management, patient access, and health benefits? 
7. What type and number of consultations are the pharmacists conducting and what are the 
routes of consultation initiation and disposal? Are these consultations in addition to GP 
workload or a replacement for (patient reported)?  
 
Evaluation has included observations of Pharmacist led consultations with patients, and interviews 
with practice staff, and the programme board team. Focus groups have also taken place between the 
evaluation team and patients attending services.  
 
The University of Nottingham will also be involved in evaluating the NHS England Clinical Pharmacist 
programme pilot and second wave implementation. 
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Appendix B 
 
 
DATA RECORD 
No Filename and description Type Who / Which site Date 
1. 4101 Initial site visit Fieldnote 4000 01/10/15 
1b.  7001 Stakeholder meeting ethnographic fieldnotes Fieldnote 7000 23/10/15 
2.  8101 Commissioner meeting Meeting notes Commissioners / All 28/01/16 
3.  8102 Commissioner teleconference Meeting notes Commissioners / All 02/02/16 
4.  1101 Initial site visit Fieldnote 1000 03/02/2016 
4b.  8103 Commissioner meeting Meeting notes Commissioners / All 03/02/2016 
5. 1102 Initial Observation Fieldnote 1000 CP 11/02/2016 
6. 1103 CP Interview Interview data 1000 CP 11/02/2016 
7. 1104 PM Interview Interview data 1000 PM 11/02/2016 
8. 1105 GP Interview Interview data 1000 GP 11/02/2016 
9. 7101 Stakeholder meeting Observational meeting notes Stakeholders / All 12/02/2016 
10. 7102 Stakeholder slides Presentation notes Stakeholders / All 12/02/2016 
11. 7103 Stakeholder delegate feedback 
Delegate 
feedback Stakeholders / All 12/02/2016 
12. 3101 Initial site visit Meeting note 3000 26/02/2016 
13. 2101 Initial site visit Fieldnote 2000 01/03/2016 
14. 8104 Commissioner interview Interview data Commissioners / All 02/03/2016 
15. 2102 Initial observation Fieldnote 2000 17/03/2016 
16. 2103 CP Interview Interview data 2000 CP 17/03/2016 
17. 2104 PM Interview Interview data 2000 PM 17/03/2016 
18. 2105 GP Interview Interview data 1000 GP 17/03/2016 
19. 3102 Initial observation Fieldnotes 3000 All 18/3/16 
20. 3103 CP Interview Interview data 3000 CP  18/3/16 
21. 9101 Clinical skills training observation Fieldnotes 9000 All 22/3/16 
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22. 7104 Reflective fieldnote on difficulties contacting practices Fieldnotes 7000 All 31/3/16 
23. 9102 Clinical skills training obs Fieldnotes 9000 all 13/4/16 
24. 1106 Follow up initial observation  Fiednotes 1000 PM 27/4/16 
25. 1107 Nurse interview 1 Interview data 1000 NS 27/4/16 
26. 1108 Nurse interview 2 Interview data 1000 NS 27/4/16 
27. 8105 Teleconference with Gerald Meeting notes 8000 All 28/4/16 
28. 9103 Clinical skills training obs Fieldnotes (paper) 9000 All 6/5/16 
29. 9104 Clinical skills OSCE obs Fieldnotes (paper) 9000 All 16/5/16 
29b. 9105 Combined training delegate feedback 
Delegate 
feedback (paper) 9000 All 17/5/16 
30. 9106 Clinical Skills training provider interview Interview data 9000 All 16/5/16 
31. 9107 Training feedback report Written report 9000 All 25/5/16 
32. 7105 Update from Gerald via Matt Meeting notes 7000 All 18/5/16 
33. 3104 CP Observation in care home Fieldnotes 3000 CP 19/5/16 
34. 7106 Monthly report to commissioners Written report 9000 All 31/5/16 
35. 5101 Initial site visit Fieldnotes 5000 All 6/6/16 
36. 7102 Commissioner Interview (Sam) Interiew 7000 17/6/16 
37. 5102 First observations of Pharmacist Observations 5000 23/6/16 
38. 5103 GP Interview Interview data 5000 23/6/16 
39. 5104 PM Interview Interview data 5000 23/6/16 
40. 5105 CP Interview Interview data 5000 23/6/16 
41. 3105 PM Interview Abbey Interview data 3000 24/6/16 
42. 3106 Nurse Interview Abbey Interview data 3000 24/6/16 
43. 3107 Commissioner Interview  (Richard Wells) Interview data 3000 12/07/16 
44. 6101 Initial observation Observations 6000 14/7/16 
45.  6102 Patient feedback Written report 6000 14/7/16 
46. 6103 CP Interview Interview 6000 14/7/16 
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47. 6104 Nurse Interview  Interview 6000 14/7/16 
48. 6105 PM Interview Interview 6000 14/7/16 
49. 4102 Observation  Observation 4000 20/7/16 
50. 4103 CP Interview Interview 4000 20/7/16 
51. 1109 observations Observations 1000 14/9/16 
52. 1110 CP interview Interview  14/9/16 
53. 6106 Second clinical observations Observation 6000 16/9/16 
54. 6107 CP Second interview Interview 6000 16/9/16 
55. 4104 Interview PD   1/12/16 
56. 4105 Interview GP   1/12/16 
57. 3108 Interview GP Interview 3000 7/1/16 
58. 7103 Clinical ommissioner interview  Interview 7000 24/1/16 
59. 3109 CP Second interview Interview 3000 8/2/16 
60. 6109 CP final interview and obs Interview 6000 10/2/16 
61. 5106 CP Interview Interview 5000 5/5/16 
62. 5107 CP later obs Observation 5000 5/5/16 
63. 5108 CP Support info Paper 5000 5/5/16 
64. 1111 Focus groups Interview 1000  
65. 3108 Focus Groups Interview 3000  
66. 4106 Focus groups Interview 4000  
67. 5108 Focus Groups Interview 5000  
68. 6110 Focus Groups Interview 6000  
69. Reflection on patient data Fieldnotes All  
70. Final closure report Written report All  
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Appendix C 
 
Information sheet: Modifiable and Non-modifiable risks of T2DM 
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Information sheets: Weight Management Information Leaflet 
Weight management Advice 
The science of slimming  
 
 
1. Don’t miss meals  
Have 3 meals a day so that you don’t snack in between on junk 
food 
    
2. Count calories     1300 – 1500 per day 
 
3. Mushy/Soupy food makes you fill full up for longer because of 
slower gastric emptying time       
        
4. Protein in diet also makes you feel fuller for longer   
       
5. Add vegetables and salads to the diet – minerals and fibre – makes 
you feel fuller for longer       
     
6. Milk – slows the gastric emptying rate     
      
7. Water or juices dilute the food and empty the stomach quickly 
making you feel hungry sooner      
     
8. Smaller plate – we try to eat all that is on our plates. Care: More 
appetising the food, the more we eat. 
  
9. Exercise – continues to burn energy over 24 hours to replace the 
carbohydrates from fats. Government recommends - 5 x half hour 
moderately active exercise per week.     
 
10. Do work moving around to burn up energy  
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Waist Sizes 
 
What is your body shape? 
Most people are apple-shaped or pear-shaped. This means that when you put on weight, the fat is either 
stored around your hips (pear-shaped) or around your middle (apple-shaped).  
If you're overweight and apple-shaped, you have a higher risk of health problems than if you're 
pear-shaped. 
Waist size and risk of health problems 
You have a higher risk of health problems including T2DM if your waist size is: 
• more than 94cm (37 inches) if you're a white  or a black man  
• more than 87.5cm (35 inches) for Asian man 
• more than 80cm (31.5 inches) if you're a woman  
Your risk of health problems is even higher if your waist size is: 
• more than 102cm (40 inches) if you're a man   
• more than 88cm (34.5 inches) if you're a woman   
  
The research, which is to be published in the journal PLoS Medicine, was based on the 
EU-funded InterAct study, in which 12,403 people developed Type 2 diabetes over a 15-
year follow-up period.  
The researchers found that 7 per cent of men and 4.4 per cent of women who were 
overweight (with a BMI between 25 and 29.9kg/m2) and had a large waist went on to 
develop diabetes within 10 years.  
This contrasts with those people with normal body weight and a smaller waist 
circumference, with only 1.2 per cent of men and 0.6 per cent of women developing 
the condition over the same time period. 
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Patient Commitment to living Longer Healthier and Happier Sign up 
 
 
Commitment to Living Longer, Healthier and Happier           
 
Patient Name:  
 
 
I am going to: 
 
Stepping 
stone - 1 
Stepping stone 
- 2 
 
Target 
Diet: 
 Reg small meals. Do not 
miss meals out. Balance food 
 
 
Coffee - no more than 5 a 
day  
 
Take you meds regularly 
 
   
Stop smoking 
 
   
Exercise: 5 x 30 mins a week. 
 
   
Coffee - reduce to 5 x a day 
 
   
Encouraged to re-book the 
endoscopy and colonoscopy 
and if any issues let the 
surgery know so that we can 
resent another letter. 
   
 
I am focused and determined to get there …… 
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Information Sheets: Health Education - Obesity Diabetes and Cardiovascular Disease  
 
